976 related articles for article (PubMed ID: 26467665)
21. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
[TBL] [Abstract][Full Text] [Related]
23. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
[TBL] [Abstract][Full Text] [Related]
24. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
[TBL] [Abstract][Full Text] [Related]
25. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
[TBL] [Abstract][Full Text] [Related]
26. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.
Chan AT; Lo YM; Zee B; Chan LY; Ma BB; Leung SF; Mo F; Lai M; Ho S; Huang DP; Johnson PJ
J Natl Cancer Inst; 2002 Nov; 94(21):1614-9. PubMed ID: 12419787
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
28. Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study.
Chen QY; Guo SY; Tang LQ; Lu TY; Chen BL; Zhong QY; Zou MS; Tang QN; Chen WH; Guo SS; Liu LT; Li Y; Guo L; Mo HY; Sun R; Luo DH; Zhao C; Cao KJ; Qian CN; Guo X; Zeng MS; Mai HQ
Cancer Res Treat; 2018 Jul; 50(3):861-871. PubMed ID: 28903550
[TBL] [Abstract][Full Text] [Related]
29. Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy.
Yang L; Hong S; Wang Y; Chen H; Liang S; Peng P; Chen Y
Sci Rep; 2015 Oct; 5():15638. PubMed ID: 26497224
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
[TBL] [Abstract][Full Text] [Related]
31. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
[TBL] [Abstract][Full Text] [Related]
32. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
[TBL] [Abstract][Full Text] [Related]
33. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
35. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
[TBL] [Abstract][Full Text] [Related]
36. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.
Hui EP; Li WF; Ma BB; Lam WKJ; Chan KCA; Mo F; Ai QYH; King AD; Wong CH; Guo R; Poon DMC; Tong M; Li L; Lau TKH; Wong KCW; Lam DCM; Lo YMD; Ma J; Chan ATC
Ann Oncol; 2020 Jun; 31(6):769-779. PubMed ID: 32217076
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
38. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
[TBL] [Abstract][Full Text] [Related]
39. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
40. Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
Lu ZJ; Liu LT; Sun XS; Guo SS; Yang Q; Liu SL; Li XY; Qiu HZ; Yang ZC; Xiao BB; Lin C; Luo DH; Sun R; Lin HX; Chen QY; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2021 Sep; 162():202-211. PubMed ID: 33839207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
